What we're reading, December 9, 2015: the federal government recovered $200 million from state's whose health insurance exchanges faltered; drug cocktails are responsible for majority of drug overdose deaths in Massachusetts; and healthcare organizations are not confident in their ability to share patient data while protecting patient privacy.
The Affordable Care Act remains a controversial topic in the United States, but the government recently announced it has been able to recoup more than $200 million in funding from states that tried to set up their own health insurance exchanges and ran into problems. The federal government had granted more than $4 billion to 17 states, but exchanges have struggled and Hawaii, Nevada, and Oregon all chose to close their exchanges, reported The Wall Street Journal.
The majority of drug overdose deaths in Massachusetts are being attributed to drug cocktails that combine a prescription opioid or heroin with some other drug or alcohol. Kaiser Health News reported that an analysis from the Harvard T.H. Chan School of Public Health found fentanyl, which is more powerful than heroin, was present in more than one-third of the deaths. Even physicians specializing in addiction medicine and who treat patients in recovery face the challenge of what to prescribe that won’t cause a serious adverse reaction.
Demand for access to health data is on the rise, but healthcare organizations might not be able to ensure patient privacy, according to a new survey. More than two-thirds of healthcare organizations lack complete confidence in their ability to share data without risking patients’ privacy, according to Healthcare Informatics. In addition, the survey found individuals lack familiarity with advanced methods of de-identifying data and most organizations use data sharing approaches that increase risk.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More